Nov 06, 2020 / 01:30PM GMT
Operator
Greetings. Welcome to Matinas BioPharma Third Quarter 2020 Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to Peter Vozzo, Investor Relations Representative for Matinas BioPharma. You may begin.
Peter Vozzo - Westwicke Partners, LLC - MD
Thank you, Latonya. Good morning, everyone, and thank you for joining the Matinas BioPharma third quarter 2020 results conference call. Earlier this morning, we issued a press release with our third quarter 2020 financial results along with business updates. The release is available on the Matinas BioPharma website under the Investors section.
Speaking on today's call would be Jerry Jabbour, Chief Executive Officer, who would discuss the company's corporate progress and key milestones; and Keith Kucinski, Chief Financial Officer, who will then review third quarter financial results. We also have Dr. Terry Matkovits, Chief Development Officer; and Dr. Terry Ferguson, Chief Medical Officer, available to answer
Q3 2020 Matinas BioPharma Holdings Inc Earnings Call Transcript
Nov 06, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers